Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia

Circulation Research

Volumn 92, Issue 11, 2003, Pages 1262-1267

  Allayee, Hooman ^a   Castellani, Lawrence W ^b   Cantor, Rita M ^a   De Bruin, Tjerk W A ^c   Lusis, Aldons J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apolipoprotein A II; Genetics; Insulin resistance; Metabolic syndrome; Triglycerides

Indexed keywords

APOLIPOPROTEIN A2; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY FAT; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1Q; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; GENETIC LINKAGE; GENETICS; GLUCOSE METABOLISM; HERITABILITY; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROSATELLITE MARKER; PATHOGENESIS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; TRANSGENIC MOUSE; BLOOD; GENETIC PREDISPOSITION; MIDDLE AGED;

ADULT; APOLIPOPROTEIN A-II; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LINKAGE (GENETICS); LIPIDS; MIDDLE AGED;

EID: 0038467375     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000075600.87675.16     Document Type: Article

References (35)

1. Barbaras R, Puchois P, Fruchart JC, Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Biochem Biophys Res Commun. 1987;142:63-69.
2. Castellani LW, Navab M, Van Lenten BJ, Hedrick CC, Hama SY, Goto AM, Fogelman AM, Lusis AJ. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest. 1997;100:464-474.
3. Castro G, Nihoul LP, Dengremont C, de Geitere C, Delfly B, Tailleux A, Fievet C, Duverger N, Denefle P, Fruchart JC, Rubin EM. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-β particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Biochemistry. 1997;36:2243-2249.
4. Deeb SS, Takata K, Peng RL, Kajiyama G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet. 1990;46:822-827.
5. Warden CH, Hedrick CC, Qiao JH, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469-472.
6. Castellani LW, Goto AM, Lusis AJ. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance. Diabetes. 2001;50:643-651.
7. Weng W, Breslow JL. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc Natl Acad Sci U S A. 1996;93:14788-14794.
8. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Bums DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 1998;63:1130-1138.
9. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes. 1999;48:1175-1182.
10. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Lepretre F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froguel P. Genome wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet. 2000;67:1470-1480.
11. Warden CH, Daluiski A, Bu X, Purcell-Huynh DA, De Meester C, Shieh BH, Puppione DL, Gray RM, Reaven GM, Chen YD, et al. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. Proc Natl Acad Sci U S A. 1993;90:10886-10890.
12. Hong SH, Kang BY, Park WH, Kim JQ, Lee CC. Association between apolipoprotein A2 MspI polymorphism and hypertriglyceridemia in Koreans. Hum Biol. 1998;70:41-46.
13. Aouizerat BE, Allayee H, Bodnar J, Krass KL, Peltonen L, de Bruin TW, Rotter JI, Lusis AJ. Novel genes for familial combined hyperlipidemia. Curr Opin Lipidol. 1999;10:113-122.
14. Voors-Pette C, de Bruin TW. Excess coronary heart disease in familial combined hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis. 2001;157:481-489.
15. Escola-Gil JC, Julve J, Marzal-Casacuberta A, Ordonez-Llanos J, Gonzalez-Sastre F, Blanco-Vaca F. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J Lipid Res. 2000;41:1328-1338.
16. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TWA. Complex genetic contribution of the apoAICIII-AIV gene cluster to familial combined hyperlipidemia. J Clin Invest. 1997;97:953-961.
17. Dallinga-Thie GM, Bu X, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TWA. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res. 1996;37:136-147.
18. Allayee H, de Bruin TW, Michelle Dominguez K, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension. 2001;38:773-778.
19. Castro Cabezas M, de Bruin TWA, de Valk HA, Shoulders CC, Jansen H, Erkelens DW. Impaired fatty acid metabolism in familial combined hyperlipidemia. J Clin Invest. 1993;92:160-168.
20. Yuan B, Vaske D, Weber JL, Beck J, Sheffield VC. Improved set of short tandem repeat polymorphisms for screening the human genome. Am J Hum Genet. 1997;60:459-460.
21. Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, de Bruin TWA, Rotter JI, Lusis AJ. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11. Am J Hum Genet. 1999;65:397-412.
22. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford, UK: Clarendon Press; 1994.
23. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
24. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 1995;57:439-454.
25. Ott J. Methods of Linkage Analysis: Nonparametric Approaches. Baltimore, Md: Johns Hopkins University Press; 1991.
26. Brousseau T, Dupuy-Gorce AM, Evans A, Arveiler D, Ruidavets JB, Haas B, Cambou JP, Luc G, Ducimetiere P, Amouyel P, Helbecque N. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subtractions: the ECTIM study. Am J Med Genet. 2002;110:19-24.
27. van der Kallen C, Voors-Pette C, Bouwman F, Keizer H, Lu J, van de Hulst R, Bianchi R, Janssen M, Keulen E, Boeckx W, Rotter J, de Bruin T. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. Atherosclerosis. 2002;164:337-346.
28. Escola-Gil JC, Marzal-Casacuberta A, Julve-Gil J, Ishida BY, OrdonezLlanos J, Chan L, Gonzalez-Sastre F, Blanco-Vaca F. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. J Lipid Res. 1998;39:457-462.
29. Davis RC, Raffel LJ, Castellani LW, Cheng LS, Quinones M, Wen P, Xiang AH, Tan S, Buchanan TA, Hsueh WA, Rotter JI. Quantitative trait locus mapping for human genes regulating plasma levels of apolipoprotein A2, a protein important in obesity and insulin resistance. Circulation. 2001:104(suppl II):II-235. Abstract.
30. Klos KL, Kardia SL, Ferrell RE, Turner ST, Boerwinkle E, Sing CF. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 2001;21:971-978.
31. Eurlings PM, van der Kallen CJ, Geurts JM, van Greevenbroek MM, de Bruin TW. Genetic dissection of familial combined hyperlipidemia. Mol Genet Metab. 2001;74:98-104.
32. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KV, Ylitalo K, Pihlajamaki J, Suomalainen AJ, Syvanen AC, Lehtimaki T, Viikari JS, Laakso M, Taskinen MR, Ehnholm C, Peltonen L. Linkage of familial combined hyperlipidaemia to chromosome Iq21-q23. Nat Genet. 1998;18:369-373.
33. Allayee H, Krass KL, Pajukanta P, Cantor RM, van der Kallen CJ, Mar R, Rotter JI, de Bruin TW, Peltonen L, Lusis AJ. Locus for elevated apolipoprotein B levels on chromosome Ip31 in families with familial combined hyperlipidemia. Circ Res. 2002;90:926-931.
34. Cortner JA, Coates PM, Bennett MJ, Cryer DR, Le NA. Familial combined hyperIipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver. J Inherit Metab Dis. 1991;14:915-922.
35. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:1110-1118.